Francesca Della Casa

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Multiple Myeloma

Atopic Dermatitis

Top Venues

Diagnostics (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Massimiliano Mancini, Giovanni Di Nardo, Emanuele Casciani, Maria Letizia Feudi, Lavinia Bargiacchi, Angelica Petraroli, Francesca Della Casa, Arianna Di Napoli, Andrea Vecchione
The Multifaceted Complexity of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS): A Case Report Highlighting Atypical Gastrointestinal Manifestations. Diagnostics (Basel, Switzerland) 14 (13) (2024)
Massimiliano Mancini, Giovanni Di Nardo, Emanuele Casciani, Maria Letizia Feudi, Lavinia Bargiacchi, Angelica Petraroli, Francesca Della Casa, Arianna Di Napoli, Andrea Vecchione
The Multifaceted Complexity of Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS): A Case Report Highlighting Atypical Gastrointestinal Manifestations. Diagnostics (Basel, Switzerland) 14 (13) (2024)
Ilaria Mormile, Fabiana Tuccillo, Francesca Della Casa, Valentina D'Aiuto, Nunzia Montuori, Marina De Rosa, Filomena Napolitano, Amato de Paulis, Francesca Wanda Rossi
The Benefits of Water from Nitrodi's Spring: The In Vitro Studies Leading the Potential Clinical Applications. International journal of molecular sciences 24 (18) (2023)
Maria Rosaria Galdiero, Ilaria Mormile, Francescopaolo Granata, Stefania Loffredo, Aikaterini Detoraki, Francesca Della Casa, Maria Luisa Trocchia, Annagioia Ventrici, Amato de Paulis, Francesca Wanda Rossi
Functional Modulation of Human Macrophages by Secreted Phospholipases A 2 : Implications in Cancer. Biomedicines 10 (11) (2022)
Ilaria Mormile, Francescopaolo Granata, Aikaterini Detoraki, Daniela Pacella, Francesca Della Casa, Felicia De Rosa, Antonio Romano, Amato de Paulis, Francesca Wanda Rossi
Predictive Response to Immunotherapy Score: A Useful Tool for Identifying Eligible Patients for Allergen Immunotherapy. Biomedicines 10 (5) (2022)